Commissioning and Qualification (Second Edition)
The industry guide that operationalises ASTM E2500’s risk- and science-based approach into an integrated commissioning and qualification lifecycle. It introduces the System Risk Assessment, Critical Aspects, and Critical Design Elements (CDEs), and folds commissioning and qualification into a single verification effort.
What this does not cover
stated in the document's own scope- Guidance operationalising qualification, not a binding regulation; the legal requirement remains EU GMP Annex 15 / 21 CFR 211.
- Covers commissioning and qualification of facilities, utilities, and equipment, not the ongoing process validation of the product.
- Addresses engineering systems, not computerised-system validation, which follows GAMP 5 and EU GMP Annex 11.
Always verify against the current published text before relying on it for a submission or inspection.
Overview
ISPE Baseline Guide Volume 5, Commissioning and Qualification, is the industry guide that turns ASTM E2500’s risk- and science-based approach into a practical, integrated lifecycle. The Second Edition (2019) folds commissioning and qualification into a single verification effort rather than treating them as separate exercises. It introduces the System Risk Assessment, the identification of Critical Aspects, and Critical Design Elements (CDEs) — the design features that must be verified because they affect product quality and patient safety — and shows how vendor documentation and Good Engineering Practice can carry qualification evidence when the risk assessment supports it.
Scope & applicability
Commissioning and qualification of facilities, utilities, and equipment used in regulated manufacturing, across the design, verification, and acceptance lifecycle.
Legal basis & how it acquires force
The guide is published by ISPE (the International Society for Pharmaceutical Engineering) as best-practice guidance; it is not a statute or regulation and creates no legal duty of its own. It acquires force through the GMP frameworks whose qualification requirements it helps satisfy — EU GMP Annex 15 (Qualification and Validation) and 21 CFR Part 211. A site remains obligated by those instruments; the Baseline Guide is a recognised route to demonstrating that facilities, utilities, and equipment are qualified in a risk-proportionate way.
Document structure
| Part | Covers |
|---|---|
| C&Q lifecycle and integration | Combining commissioning and qualification into one verification effort across the project lifecycle |
| System risk assessment | Assessing systems against product quality and patient safety to focus qualification effort |
| Critical Aspects and CDEs | Identifying Critical Aspects and Critical Design Elements that must be verified |
| Design review and qualification | Design review, verification planning, and acceptance of critical design elements |
| Good Engineering Practice and vendor documentation | Leveraging GEP and supplier documentation as qualification evidence |
| Change management and handover | Managing change during the project and system handover to operation |
Key requirements
- System Risk Assessment to focus qualification on Critical Aspects
- Identification of Critical Design Elements during design review
- Integrated commissioning and qualification to avoid duplicate testing
- SME-led verification with documented quality-unit approval
Implementation tips
- Run the design review early to capture CDEs before construction locks them in
- Reuse commissioning and FAT/SAT evidence in qualification where risk allows — document the justification
- Keep the requirements → risk → verification thread traceable per system
Revision notes
Second Edition (2019) replaced the 2001 first edition, aligning C&Q to ASTM E2500 and ICH Q8/Q9/Q10. It is the primary implementation reference for risk-based C&Q.
Where this control fails
live FDA enforcementLive FDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.
International alignment
Volume 5 is deliberately aligned with ASTM E2500, which supplies the underlying risk- and science-based principles, and it maps onto the qualification outcomes EU GMP Annex 15 and 21 CFR 211 require. It draws on the wider ICH toolkit — quality risk management from ICH Q9 and product/process understanding from ICH Q8 — so the C&Q programme it describes fits within a company’s pharmaceutical quality system under ICH Q10.
ISPE Baseline Guide Vol. 5 (2019): frequently asked questions
Quick answers to common questions about ISPE Baseline Guide Vol. 5 (2019).
Which edition of the ISPE C&Q Baseline Guide is current?
The Second Edition, published in 2019. It replaced the earlier commissioning-and-qualification guidance and was written to align with ASTM E2500.
What are Critical Design Elements (CDEs)?
CDEs are the design features of a system that must be verified because they are necessary to control a Critical Aspect affecting product quality or patient safety. Identifying them focuses qualification effort where it matters.
How does the Baseline Guide relate to ASTM E2500?
ASTM E2500 sets the risk- and science-based principles; ISPE Baseline Guide Vol. 5 operationalises them into an integrated commissioning-and-qualification lifecycle with practical tools such as the System Risk Assessment and CDEs.
This standard in practice
Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.